VEGF-specific capture agents, compositions, and methods of using and making
US9221889B2 · kind B2 · utility
8Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2014 |
| Grant date | Dec 29, 2015 |
| Priority date | — |
| Expiry date | Jan 7, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/16
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present application provides biligand and triligand protein-catalyzed capture (PCC) agents that specifically bind VEGF, as well as the use of these capture agents as detection, diagnosis, and treatment agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.